Back to top
more

Clorox (CLX)

(Real Time Quote from BATS)

$122.33 USD

122.33
329,464

-2.54 (-2.03%)

Updated Aug 11, 2025 10:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (168 out of 244)

Industry: Consumer Products - Staples

Zacks News

Zacks Equity Research

Lamb Weston (LW) Q4 Earnings Lag Estimates, Sales Down Y/Y

Lamb Weston's (LW) fourth-quarter fiscal 2020 sales decline due to lower demand in the Foodservice and Global segment amid the coronavirus outbreak.

Zacks Equity Research

Will Tyson Foods' (TSN) Q3 Earnings Reflect Coronavirus Woes?

Tyson Foods' (TSN) third-quarter results are likely to reflect soft foodservice volumes and elevated cost of production due to the coronavirus pandemic.

Zacks Equity Research

Things You Must Know Ahead of AB InBev's (BUD) Q2 Earnings

Softness in the on-premise channel due to closure of restaurants and bars is expected to have marred AB InBev's (BUD) top line in Q2. E-commerce sales are likely to partly cushion results.

Zacks Equity Research

Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings

Retail store closures and supply chain disruptions might show on Newell's (NWL) second-quarter 2020 results.

Zacks Equity Research

Is Colgate (CL) Poised to Beat Earnings Estimates in Q2?

Colgate's (CL) second-quarter 2020 sales are likely to have benefited from investment in brands, favorable pricing strategy, innovative product launches and enhancement of e-commerce capabilities.

Zacks Equity Research

How is Keurig Dr Pepper (KDP) Placed Ahead of Q2 Earnings?

Higher adjusted operating margin, a lower effective tax rate and reduced interest expenses might show on Keurig Dr Pepper's (KDP) bottom line in second-quarter 2020.

Zacks Equity Research

Clorox (CLX) Earnings Expected to Grow: Should You Buy?

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Factors Likely to Impact Pilgrim's Pride's (PPC) Q2 Earnings

Macroeconomic headwinds in Mexico and high input costs are likely to get reflected in Pilgrim's Pride's (PPC) Q2 performance. Nevertheless, strength in Prepared Foods unit bodes well.

Zacks Equity Research

Here's How Kraft Heinz (KHC) Looks Ahead of Q2 Earnings

Increased demand owing to higher at-home consumption amid the coronavirus outbreak is likely to get reflected in Kraft Heinz's (KHC) second-quarter 2020 performance.

Zacks Equity Research

Kellogg (K) to Report Q2 Earnings: Is a Beat in the Cards?

Kellogg's (K) second-quarter results are likely to reflect high demand amid pandemic-led increased at-home consumption. However, adverse impacts of divestitures and currency volatility are concerns.

Zacks Equity Research

Here's How B&G Foods (BGS) Looks Just Ahead of Q2 Earnings

B&G Foods' (BGS) second-quarter results are likely to reflect higher demand amid coronavirus-led increased at-home consumption. Also, the company's pricing strategy and saving efforts bode well.

Zacks Equity Research

Things to Note Ahead of Procter & Gamble's (PG) Q4 Earnings

Strong demand for Procter & Gamble's (PG) products, which are deemed essential, is likely to have aided performance in fiscal fourth quarter.

Zacks Equity Research

Soft On-Premise Sales to Mar Molson Coors' (TAP) Q2 Earnings

Molson Coors' (TAP) second-quarter 2020 results are likely to reflect significant impacts from the closure of on-premise sales channels in almost all markets and other headwinds on the global economy.

Zacks Equity Research

Boston Beer (SAM) Stock Up on Q2 Earnings Beat, Sales Up Y/Y

Boston Beer's (SAM) Q2 results gain from solid depletion growth along with strength in Truly Hard Seltzer and Twisted Tea as well as the Dogfish Head brands.

Zacks Equity Research

Factors Likely to Decide Archer Daniels' (ADM) Q2 Earnings

Soft results across the Carbohydrate Solutions, and Ag Services and Oilseeds segments might show on Archer Daniels' (ADM) second-quarter 2020 results.

Zacks Equity Research

Clorox (CLX) Soars to 52-Week High, Time to Cash Out?

Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Rajani Lohia headshot

Soap & Cleaning Materials Industry Outlook Bubbling With Optimism

Escalated demand for hand sanitizers, toilet paper, surface cleaners, disinfecting wipes and other household cleansing essentials are likely to aid Soap & Cleaning Materials players in the near term.

Zacks Equity Research

Kimberly-Clark (KMB) Q2 Earnings & Sales Top Estimates

Kimberly-Clark (KMB) generates robust cost savings in second-quarter 2020. Also, the company witnesses strong demand in the Consumer Tissue segment amid the coronavirus outbreak.

Zacks Equity Research

Clorox (CLX) Gains But Lags Market: What You Should Know

Clorox (CLX) closed the most recent trading day at $227.55, moving +0.36% from the previous trading session.

Zacks Equity Research

Here's How Mondelez (MDLZ) Looks Ahead of Q2 Earnings

Impacts of higher customer service, labor and logistics costs are likely to get reflected in Mondelez's (MDLZ) second-quarter 2020 performance.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Clorox (CLX)

Clorox (CLX) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Here's How Kimberly-Clark (KMB) Looks Ahead of Q2 Earnings

Increased demand owing to consumer stockpiling trends amid the coronavirus outbreak is likely to get reflected in Kimberly-Clark's (KMB) second-quarter 2020 performance.

Zacks Equity Research

Factors to Decide the Fate of Coca-Cola (KO) in Q2 Earnings

Coca-Cola's (KO) Q2 results are likely to reflect the impacts of declines in away-from-home channels and adverse currency. Growth in e-commerce is likely to have party cushioned its performance.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg

The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg

Zacks Equity Research

Boston Beer (SAM) to Report Q2 Earnings: What to Expect?

Boston Beer's (SAM) Q2 results are likely to reflect continued gains from strength in depletions and shipments. Soft on-premise demand and higher costs are expected to have marred its performance.